HK52791A - Derivatives of 2,2'-iminobisethanol - Google Patents

Derivatives of 2,2'-iminobisethanol Download PDF

Info

Publication number
HK52791A
HK52791A HK527/91A HK52791A HK52791A HK 52791 A HK52791 A HK 52791A HK 527/91 A HK527/91 A HK 527/91A HK 52791 A HK52791 A HK 52791A HK 52791 A HK52791 A HK 52791A
Authority
HK
Hong Kong
Prior art keywords
parts
formula
dihydro
benzopyran
alkyl
Prior art date
Application number
HK527/91A
Other languages
German (de)
English (en)
French (fr)
Inventor
Guy Rosalia Eugene Van Lommen
Marcel Frans Leopold De Bruyn
Marc Francis Josephine Schroven
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HK52791A publication Critical patent/HK52791A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK527/91A 1983-12-05 1991-07-11 Derivatives of 2,2'-iminobisethanol HK52791A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55808183A 1983-12-05 1983-12-05

Publications (1)

Publication Number Publication Date
HK52791A true HK52791A (en) 1991-07-19

Family

ID=24228139

Family Applications (1)

Application Number Title Priority Date Filing Date
HK527/91A HK52791A (en) 1983-12-05 1991-07-11 Derivatives of 2,2'-iminobisethanol

Country Status (32)

Country Link
EP (1) EP0145067B1 (cs)
JP (1) JPS60132977A (cs)
KR (1) KR870000923B1 (cs)
AR (1) AR241414A1 (cs)
AT (1) ATE40361T1 (cs)
AU (1) AU573658B2 (cs)
BG (1) BG43866A3 (cs)
CA (1) CA1337429C (cs)
CS (1) CS250242B2 (cs)
CY (1) CY1609A (cs)
DD (1) DD235453A5 (cs)
DE (1) DE3476388D1 (cs)
DK (2) DK165112C (cs)
DZ (1) DZ712A1 (cs)
ES (1) ES538256A0 (cs)
FI (1) FI82460C (cs)
GR (1) GR81098B (cs)
HK (1) HK52791A (cs)
HU (1) HU202219B (cs)
IE (1) IE57831B1 (cs)
IL (1) IL73706A (cs)
MA (1) MA20292A1 (cs)
NO (2) NO169839C (cs)
NZ (1) NZ210388A (cs)
PH (1) PH22432A (cs)
PL (1) PL146342B1 (cs)
PT (1) PT79609B (cs)
RO (1) RO91184B (cs)
SG (1) SG47091G (cs)
SU (1) SU1428199A3 (cs)
ZA (1) ZA849445B (cs)
ZW (1) ZW19784A1 (cs)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02103116U (cs) * 1989-02-01 1990-08-16
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd ６―フルオロクロモン―２―カルボン酸及びその製造法
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
RU2129556C1 (ru) * 1993-08-19 1999-04-27 Жансен Фармасетика Н.В. Производное дигидробензопирана, обладающее сосудосуживающим действием, промежуточные соединения, способы получения, фармацевтическая композиция и способ ее получения
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
BR9709556A (pt) * 1996-06-07 1999-08-10 Procter & Gamble Dihidrobenzopirano e compostos a ele relacionados úteis como agentes antiflamatórios
EP1040106B1 (en) * 1997-12-19 2002-08-28 Bayer Corporation Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
EP1408964B1 (en) 2001-07-26 2007-01-24 MERCK PATENT GmbH Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts
WO2003042160A1 (en) 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
BRPI0513672A (pt) 2004-07-30 2008-05-13 Torrent Pharmaceuticals Limita processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
PL1776354T3 (pl) * 2004-08-11 2010-09-30 Hetero Drugs Ltd Nowy sposób wytwarzania związków pośrednich nebiwololu
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
WO2006083779A2 (en) * 2005-01-31 2006-08-10 Mylan Laboratories, Inc. Pharmaceutical composition comprising hydroxylated nebivolol
SG175476A1 (en) * 2005-01-31 2011-11-28 Mylan Lab Inc Glucuronidated nebivolol metabolites
EP1850842A1 (de) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
RU2392277C2 (ru) * 2005-12-28 2010-06-20 Асино Фарма Аг Способ получения рацемического небиволола
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
WO2007083318A1 (en) 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
PL2099790T3 (pl) 2006-11-27 2010-12-31 Zach System Spa Sposób wytwarzania nebiwololu
WO2008089549A1 (en) 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1392067B1 (it) * 2008-10-31 2012-02-09 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
ES2700973T3 (es) 2014-02-14 2019-02-20 Corden Pharma Int Gmbh Proceso sin base para la preparación de compuestos intermedios de cetona que se pueden usar para fabricar nebivolol
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
KR102756069B1 (ko) 2015-05-19 2025-01-22 저장 아우선 파마슈티칼 씨오., 엘티디. 네비볼롤 합성방법 및 그의 중간 화합물
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054655A (cs) * 1964-01-24
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
PH22432A (en) 1988-09-12
JPH0250114B2 (cs) 1990-11-01
EP0145067A3 (en) 1986-03-26
DK165112C (da) 1993-03-01
DK577084A (da) 1985-06-06
CS250242B2 (en) 1987-04-16
FI844777A0 (fi) 1984-12-04
ZW19784A1 (en) 1986-07-02
DE3476388D1 (en) 1989-03-02
KR850004485A (ko) 1985-07-15
NZ210388A (en) 1987-07-31
KR870000923B1 (ko) 1987-05-07
FI844777L (fi) 1985-06-06
NO169839B (no) 1992-05-04
ES8603870A1 (es) 1986-01-01
DD235453A5 (de) 1986-05-07
RO91184B (ro) 1987-07-31
SU1428199A3 (ru) 1988-09-30
GR81098B (en) 1984-12-17
MA20292A1 (fr) 1985-07-01
EP0145067B1 (en) 1989-01-25
DK11892A (da) 1992-01-31
FI82460B (fi) 1990-11-30
IL73706A (en) 1988-07-31
SG47091G (en) 1991-07-26
PL146342B1 (en) 1989-01-31
IL73706A0 (en) 1985-03-31
NO844845L (no) 1985-06-06
DK165321C (da) 1993-03-29
HU202219B (en) 1991-02-28
PT79609B (en) 1986-12-12
DK577084D0 (da) 1984-12-04
CA1337429C (en) 1995-10-24
FI82460C (fi) 1991-03-11
HUT37418A (en) 1985-12-28
IE843103L (en) 1985-06-05
ES538256A0 (es) 1986-01-01
CY1609A (en) 1992-04-03
NO2004007I2 (no) 2005-05-09
ATE40361T1 (de) 1989-02-15
AU3632684A (en) 1985-06-13
NO169839C (no) 1992-08-12
IE57831B1 (en) 1993-04-21
DK165321B (da) 1992-11-09
PL250524A1 (en) 1986-02-25
JPS60132977A (ja) 1985-07-16
AR241414A1 (es) 1992-07-31
NO2004007I1 (no) 2004-12-20
PT79609A (en) 1985-01-01
DK11892D0 (da) 1992-01-31
DZ712A1 (fr) 2004-09-13
EP0145067A2 (en) 1985-06-19
BG43866A3 (en) 1988-08-15
AU573658B2 (en) 1988-06-16
DK165112B (da) 1992-10-12
ZA849445B (en) 1986-07-30
RO91184A (ro) 1987-07-30

Similar Documents

Publication Publication Date Title
EP0145067B1 (en) Derivatives of 2,2'-iminobisethanol
US4654362A (en) Derivatives of 2,2'-iminobisethanol
US5688952A (en) (Benzodioxan benzofuran or benzopyran) alkylamino!alkyl substituted guanidines
US5677310A (en) Vasoconstrictive substituted aryloxyalkyl diamines
US4251537A (en) Hypotensive 3,4-dihydro-2,2-dimethyl-4-amino-2H-benzo[b]pyran-3-ols
FI92824C (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI95700C (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI95250B (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
CA2114359A1 (en) Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents
FI92825B (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
JPH0320275A (ja) クロマン誘導体
SK279095B6 (sk) Deriváty chrómanu samy osebe a na liečenie chorôb,
US5236935A (en) Benzopyran derivatives and processes for the preparation thereof
EP0005610A2 (en) 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers
US5691344A (en) Vasoconstrictive substituted dihydropyranopyridines
EP0624582A1 (fr) Benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant
KR950009862B1 (ko) 벤조피란 유도체와 그의 제조방법(1)
US4883793A (en) Hydrazinocarbonyloxylabdanes for treating cardiac failure
JPS61129183A (ja) 中間化合物及びその製法
YO et al. Syntheses and β-Adrenergic Blocking Activities of the Optical Isomers of 8-Acetonyloxyl-5-[3-(3, 4-dimethoxyphenethylamino)-2-hydroxypropoxy]-3, 4-dihydrocarbostyril
US5703115A (en) (benzodioxan, benzofuran or benzopyran) alkylamino! alkyl substituted guanidines
US4332818A (en) 1,4;3,6-Dianhydro-2,5-diazido-2,5-dideoxy-hexitols
EP0571822A1 (en) Diazabicycloalkene derivatives
HK1186727A1 (en) Chromene derivatives useful in the treatment of a disease mediated by the tcr-nck interaction
JPS63130590A (ja) クロメン化合物

Legal Events

Date Code Title Description
PE Patent expired
PE Patent expired

Effective date: 20041121